Developer docs
API playgroundTry for free, no card

Search company profiles

Accellerated Biologics

Full company profile

uuid0008hsg

Namestring
Accellerated Biologics
Legal namestring
Accellerated Biologics
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Accellerated Biologics is a privately held US medical distribution company founded in 1999 and headquartered in Tequesta, Florida. The company specializes in autologous biologics and regenerative medicine, distributing a comprehensive portfolio spanning platelet-rich plasma (PRP) systems, bone marrow concentrate (BMC) systems, adipose tissue processing systems, alpha-2-macroglobulin/fibrinogen concentrates, extracellular vesicle preparations, percutaneous tenotomy devices, dual-delivery laser systems, and consumer photobiomodulation devices. Its primary customers are orthopedic surgeons, sports medicine physicians, interventional pain management specialists, dermatology and aesthetics practitioners, urologists, and OBGYNs across US academic medical centers and specialty practices.

The company's product portfolio centers on third-party manufactured systems that Accellerated Biologics markets and distributes, most notably the EmCyte PurePRP, AbsolutePRP, PureBMC, and SuperShot PRP lines; the TendoNova Ocelot Nano percutaneous tenotomy device (FDA-cleared under K212049); the Regenalase dual-laser system distributed exclusively in the US under a partnership with IPG Medical Corporation; and the in-house RegeniSTAT platelet analyzer that uses AI-assisted Viscoelastic Focusing technology for point-of-care PRP quality validation. Supporting equipment includes the Executive Series Centrifuge II and the AspiraDome aspiration device, while the Redvive PBM line comprises FDA Class II consumer-grade red and near-infrared light therapy devices. EmCyte systems have been independently validated by The Steadman Clinic's ProofPoint Biologics division, demonstrating 9-20 billion platelet yields from 7mL samples and over 9.1x total nucleated cell concentration in BMC processing within under 10 minutes at the point of care.

Accellerated Biologics generates revenue through three streams: (1) hardware and consumable biologics sales to physicians, clinics, and healthcare providers via a direct field sales force and an authorized distributor network across the United States, with most enterprise pricing conducted via quote-based negotiations; (2) clinical education and training delivered through the Regenerative Medicine Training Institute (RMTI), with tuition of $1,295 per attendee for CME-approved hands-on courses; and (3) digital marketing services sold to physician clients, encompassing social media management, review growth via Broadly, patient education brochures, content writing, and marketing automation. The company supplements its sales motion with financing through Financial Partners Group and maintains active booth presence at major orthopedic and PM&R conferences including AOSSM and AAPM&R.

Short descriptiontext

Accellerated Biologics is a US medical distribution company specializing in autologous biologics and regenerative medicine devices. It distributes EmCyte PRP and bone marrow systems, TendoNova tenotomy devices, Regenalase lasers, and Redvive photobiomodulation products to orthopedic, sports medicine, and pain management physicians.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTegueste, Spain
HQ citystring
Tegueste
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
platelet rich plasma, regenerative medicine, bone marrow concentrate, autologous biologics, photobiomodulation therapy
Industry2 codes
PRIMARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYCRAOAHAD
Specialty Pharmacy & Biologics Distribution
NAICS code1 code
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers423450
SIC code1 code
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Regenerative Medicine Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Biologics and Medical Device Product Sales
TypeHardware Sales
Description

AcCELLerated Biologics generates revenue through the sale of regenerative medicine biologics (PRP, Bone Marrow Concentrate, Adipose-derived products) and medical devices (centrifuges, lasers, analyzers, tenotomy devices) to physicians, clinics, and healthcare providers. Products are sold through direct sales, distributor networks, and e-commerce for consumer wellness devices. The company also provides associated consumable kits and accessories as recurring revenue streams.

accelleratedbiologics.com
2Education and Training Services
TypeProfessional Services
Description

Through the Regenerative Medicine Training Institute (RMTI), the company offers CME-approved hands-on training courses for physicians including PRP, bone marrow aspirate, and adipose tissue techniques. Tuition for courses such as the RMTI Course Incorporating Orthobiologics is priced at $1,295 per attendee, with small class sizes of approximately 30 participants.

accelleratedbiologics.com
3Marketing Services for Physician Practices
TypeProfessional Services
Description

The company offers a suite of marketing services to physician clients including social media management, patient education brochures, review growth, digital footprint management, content and blog writing, and marketing automation. These services represent an additional revenue stream targeting the same physician customer base.

accelleratedbiologics.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D
Pricing details5 tiers
1Redvive 60 red light therapy panel
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$999 per unit. Red and near-infrared light panel with 60x5W medical grade flicker-free LEDs, dual red/NIR switches, built-in digital timer, tabletop stand. Wavelengths: 635nm 670nm (Red) and 810nm 850nm (Near-Infrared). Power: 85W.

accelleratedbiologics.com
2Redvive 300 full body red light therapy panel
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$2,599 per unit. Full body panel with 300x3W high-quality Epiled chips, 900W LED rated power, 172.2mW/in² irradiance at 6 inches, adjustable touch pad for timer and wavelength selection. Wavelengths: 635nm 670nm RED LIGHT, 810nm 850nm NEAR INFRARED. 2-year warranty.

accelleratedbiologics.com
3Redvive 300 Adjustable Stand
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$349 per adjustable stand. Allows easy height and angle control for optimal light therapy with tool-free setup.

accelleratedbiologics.com
4Redvive Halo Hat
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$1,199 per unit. Scalp wellness device with 100 triple-wave LEDs (635nm, 670nm red, 810nm NIR), rechargeable lithium battery (~2000mAh), USB-C charging, 1-year warranty.

accelleratedbiologics.com
5RMTI Orthobiologics Training Course
ModelOtherBilling cadencePay-as-you-go
Notes

$1,295 tuition per attendee for the one-day RMTI Course Incorporating Orthobiologics. Includes didactic faculty presentations, patient procedures, ultrasound information, and hands-on multi-station techniques lab. Limited spots available.

accelleratedbiologics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 10 records shown
1PureBMC
Description

Pure Bone Marrow Concentrate product line for closed, sterile processing of bone marrow cells

accelleratedbiologics.com
+9 more records
Core offering1 text field

Accellerated Biologics is a U.S. medical distribution company that supplies regenerative medicine biologics and medical devices to physicians and healthcare providers. The portfolio spans platelet-rich plasma (PRP) systems, bone marrow concentrate devices, adipose tissue processing kits, A2M/fibrinogen kits, photobiomodulation red light therapy devices, dual-delivery musculoskeletal laser systems, and a point-of-care platelet analyzer. The company also operates the Regenerative Medicine Training Institute (RMTI) for physician education and offers marketing services to medical practices.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Accellerated Biologics offers a unified portfolio of autologous biologics products and medical devices centered on regenerative medicine. The core offering includes multiple PRP (Platelet Rich Plasma) systems (PurePRP® GS30/GS60/GS120 Pure II, AbsolutePRP GS30/GS60/GS120, SuperShot® PRP, AbsolutePRP Gold), bone marrow concentrate systems (PureBMC®, AbsoluteBMC® GSBMA30), adipose tissue processing (MAPS™ Micro Adipose Processing System, Adipose Progenikine PK25/PK50), and A2M fibrinogen products. Supporting these biologics are medical devices including the TendoNova Ocelot Nano for tendon treatment, REGENALASE™ dual-delivery laser system for musculoskeletal conditions, and Redvive PBM red light therapy devices (RV 60, RV 300, RV Halo Hat). The RegeniSTAT™ Platelet Analyzer provides real-time quality analysis of PRP output. The company serves orthopedics, sports medicine, pain management, dermatology, plastic surgery, urology, and OBGYN providers with products designed for minimally manipulated autologous cell therapies.

Product and service1 record
1PureBMC Pure Bone Marrow Concentrate
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-24
Description

AcCELLerated Biologics and Forever Labs announced a strategic partnership in June 2026 to advance stem cell storage and regenerative medicine solutions in the US. The collaboration combines biologic therapies with adult stem cell collection and cryopreservation services. Initial focus areas include physician education, training initiatives, and integrated service offerings for clinics, with Florida identified as a key market due to its supportive regulatory framework for stem cell applications.

Strategic tierCoreTypeTechnology or Integration
Description

AcCELLerated Biologics serves as the exclusive US distributor of the Regenalase Laser System from IPG Medical Corporation. The Regenalase is a dual-delivery laser platform for musculoskeletal tissue treatment. The partnership was announced in August 2025, expanding AcCELLerated Biologics' device portfolio to include advanced laser therapy alongside its biologics offerings.

Strategic tierSupportingTypeGTM or Marketing Partner
Description

AcCELLerated Biologics partnered with Broadly to provide review growth solutions to physician clients. Broadly's platform automates patient follow-up for review collection, enabling practices to build online reviews and improve search engine rankings. The partnership integrates review management into AcCELLerated Biologics' broader marketing services offering.

Strategic tierCoreTypeTechnology or Integration
Description

AcCELLerated Biologics distributes EmCyte biologic processing systems including PurePRP, AbsolutePRP, and PureBMC product lines. These EmCyte systems are central to AcCELLerated Biologics' product portfolio, offering validated high platelet concentration performance. Independent testing by institutions including The Steadman Clinic validates EmCyte systems' superiority in platelet yields and cell concentration.

Strategic tierCoreTypeTechnology or Integration
Description

AcCELLerated Biologics distributes the TendoNova Ocelot Nano device, an FDA-cleared percutaneous tenotomy system. The Ocelot Nano uses a rapidly oscillating stainless-steel cutter for tendon debridement and fragmentation, with a dedicated port for targeted biologic delivery post-procedure. The device complements AcCELLerated Biologics' PRP and biologics portfolio.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

EmCyte is the manufacturer of PurePRP, AbsolutePRP, and PureBMC systems that AcCELLerated Biologics distributes, making it both supplier and closest functional peer in the PRP/biologics category.

TypeDirect peer
Description

Apex Biologix distributes PRP kits and provides regenerative medicine training to physicians, directly overlapping AcCELLerated Biologics' PRP distribution and RMTI-style education model.

TypeDirect peer
Description

Royal Biologics is a regenerative medicine distributor offering autologous biologics kits (PRP, BMAC) to orthopedic and pain physicians, directly competing in the same product categories.

TypeDirect peer
Description

Regenexx operates a network of regenerative medicine physician clinics using autologous biologics — a competing go-to-market model in orthobiologics that intersects with the same end-market of orthopedic and sports medicine physicians.

TypeBroad incumbent
Description

Bioventus is a publicly-traded orthobiologics company offering bone graft, PRP, and HA products that compete with AcCELLerated Biologics' portfolio in sports medicine and orthopedic channels.

TypeBroad incumbent
Description

Arthrex is a large orthopedic surgical device and biologics company with its own PRP/orthobiologics line, representing a well-capitalized incumbent in AcCELLerated Biologics' core orthopedic end market.

TypeBroad incumbent
Description

Terumo BCT manufactures cell processing and blood component separation systems, overlapping with AcCELLerated Biologics' PRP/BMC processing technology stack as a broader life-sciences incumbent.

TypeBroad incumbent
Description

Zimmer Biomet is a global orthopedic medtech leader with biologics offerings (PRP, bone graft substitutes), competing for the same hospital and ambulatory surgery center customers.

TypeDirect peer
Description

Isto Biologics develops and distributes autologous and allograft orthobiologics for spine, sports medicine, and orthopedic surgeons — directly comparable to AcCELLerated Biologics' biologics portfolio.

TypeBroad incumbent
Description

Stryker is a diversified orthopedic and surgical device incumbent selling into the same physician and hospital channels targeted by AcCELLerated Biologics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers22 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Accellerated Biologics

Regenerative Medicine Medical Devicesaccelleratedbiologics.com

Accellerated Biologics is a US medical distribution company specializing in autologous biologics and regenerative medicine devices. It distributes EmCyte PRP and bone marrow systems, TendoNova tenotomy devices, Regenalase lasers, and Redvive photobiomodulation products to orthopedic, sports medicine, and pain management physicians.

What Accellerated Biologics does

Accellerated Biologics is a privately held US medical distribution company founded in 1999 and headquartered in Tequesta, Florida. The company specializes in autologous biologics and regenerative medicine, distributing a comprehensive portfolio spanning platelet-rich plasma (PRP) systems, bone marrow concentrate (BMC) systems, adipose tissue processing systems, alpha-2-macroglobulin/fibrinogen concentrates, extracellular vesicle preparations, percutaneous tenotomy devices, dual-delivery laser systems, and consumer photobiomodulation devices. Its primary customers are orthopedic surgeons, sports medicine physicians, interventional pain management specialists, dermatology and aesthetics practitioners, urologists, and OBGYNs across US academic medical centers and specialty practices.

The company's product portfolio centers on third-party manufactured systems that Accellerated Biologics markets and distributes, most notably the EmCyte PurePRP, AbsolutePRP, PureBMC, and SuperShot PRP lines; the TendoNova Ocelot Nano percutaneous tenotomy device (FDA-cleared under K212049); the Regenalase dual-laser system distributed exclusively in the US under a partnership with IPG Medical Corporation; and the in-house RegeniSTAT platelet analyzer that uses AI-assisted Viscoelastic Focusing technology for point-of-care PRP quality validation. Supporting equipment includes the Executive Series Centrifuge II and the AspiraDome aspiration device, while the Redvive PBM line comprises FDA Class II consumer-grade red and near-infrared light therapy devices. EmCyte systems have been independently validated by The Steadman Clinic's ProofPoint Biologics division, demonstrating 9-20 billion platelet yields from 7mL samples and over 9.1x total nucleated cell concentration in BMC processing within under 10 minutes at the point of care.

Accellerated Biologics generates revenue through three streams: (1) hardware and consumable biologics sales to physicians, clinics, and healthcare providers via a direct field sales force and an authorized distributor network across the United States, with most enterprise pricing conducted via quote-based negotiations; (2) clinical education and training delivered through the Regenerative Medicine Training Institute (RMTI), with tuition of $1,295 per attendee for CME-approved hands-on courses; and (3) digital marketing services sold to physician clients, encompassing social media management, review growth via Broadly, patient education brochures, content writing, and marketing automation. The company supplements its sales motion with financing through Financial Partners Group and maintains active booth presence at major orthopedic and PM&R conferences including AOSSM and AAPM&R.

Accellerated Biologics firmographics

Firmographics
Name
Accellerated Biologics
Legal name
Accellerated Biologics
Website
https://accelleratedbiologics.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
11–50 employees
Short description
Accellerated Biologics is a US medical distribution company specializing in autologous biologics and regenerative medicine devices. It distributes EmCyte PRP and bone marrow systems, TendoNova tenotomy devices, Regenalase lasers, and Redvive photobiomodulation products to orthopedic, sports medicine, and pain management physicians.
Ownership category
akta.pro rank

Accellerated Biologics industry classification

Industry
Product category
Regenerative Medicine Medical Devices
NAICS
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYCRAOAHAD
Specialty Pharmacy & Biologics Distribution

Keywords

  • Platelet rich plasma
  • Regenerative medicine
  • Bone marrow concentrate
  • Autologous biologics
  • Photobiomodulation therapy

Where Accellerated Biologics is headquartered

Location

Headquarters

HQ city
Tegueste
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Accellerated Biologics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

  1. Biologics and Medical Device Product Sales: AcCELLerated Biologics generates revenue through the sale of regenerative medicine biologics (PRP, Bone Marrow Concentrate, Adipose-derived products) and medical devices (centrifuges, lasers, analyzers, tenotomy devices) to physicians, clinics, and healthcare providers. Products are sold through direct sales, distributor networks, and e-commerce for consumer wellness devices. The company also provides associated consumable kits and accessories as recurring revenue streams.
  2. Education and Training Services: Through the Regenerative Medicine Training Institute (RMTI), the company offers CME-approved hands-on training courses for physicians including PRP, bone marrow aspirate, and adipose tissue techniques. Tuition for courses such as the RMTI Course Incorporating Orthobiologics is priced at $1,295 per attendee, with small class sizes of approximately 30 participants.
  3. Marketing Services for Physician Practices: The company offers a suite of marketing services to physician clients including social media management, patient education brochures, review growth, digital footprint management, content and blog writing, and marketing automation. These services represent an additional revenue stream targeting the same physician customer base.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goRedvive 60 red light therapy panel
Unit PricingPay-as-you-goRedvive 300 full body red light therapy panel
Unit PricingPay-as-you-goRedvive 300 Adjustable Stand
Unit PricingPay-as-you-goRedvive Halo Hat
OtherPay-as-you-goRMTI Orthobiologics Training Course

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Accellerated Biologics product offering

Product offering

Core offering

Accellerated Biologics is a U.S. medical distribution company that supplies regenerative medicine biologics and medical devices to physicians and healthcare providers. The portfolio spans platelet-rich plasma (PRP) systems, bone marrow concentrate devices, adipose tissue processing kits, A2M/fibrinogen kits, photobiomodulation red light therapy devices, dual-delivery musculoskeletal laser systems, and a point-of-care platelet analyzer. The company also operates the Regenerative Medicine Training Institute (RMTI) for physician education and offers marketing services to medical practices.

Product overview

Accellerated Biologics offers a unified portfolio of autologous biologics products and medical devices centered on regenerative medicine. The core offering includes multiple PRP (Platelet Rich Plasma) systems (PurePRP® GS30/GS60/GS120 Pure II, AbsolutePRP GS30/GS60/GS120, SuperShot® PRP, AbsolutePRP Gold), bone marrow concentrate systems (PureBMC®, AbsoluteBMC® GSBMA30), adipose tissue processing (MAPS™ Micro Adipose Processing System, Adipose Progenikine PK25/PK50), and A2M fibrinogen products. Supporting these biologics are medical devices including the TendoNova Ocelot Nano for tendon treatment, REGENALASE™ dual-delivery laser system for musculoskeletal conditions, and Redvive PBM red light therapy devices (RV 60, RV 300, RV Halo Hat). The RegeniSTAT™ Platelet Analyzer provides real-time quality analysis of PRP output. The company serves orthopedics, sports medicine, pain management, dermatology, plastic surgery, urology, and OBGYN providers with products designed for minimally manipulated autologous cell therapies.

Differentiator

Problem solved

Functional benefit

Brands

  • PureBMC: Pure Bone Marrow Concentrate product line for closed, sterile processing of bone marrow cells
  • AbsolutePRP
  • PurePRP
  • SuperShot PRP
  • MAPS
  • RegeniSTAT
  • Redvive
  • REGENALASE
  • TendoNova Ocelot Nano
  • Regenerative Medicine Training Institute (RMTI)

Products and services

  • PureBMC Pure Bone Marrow Concentrate

Companies that use Accellerated Biologics

Customer profile

Named customers22 records

Segments5 records

Ideal customer profiles3 records

Accellerated Biologics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature8 records

Accellerated Biologics partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and supporting.

  • Forever LabscoreStrategic or Co-development Partner · 24 June 2026AcCELLerated Biologics and Forever Labs announced a strategic partnership in June 2026 to advance stem cell storage and regenerative medicine solutions in the US. The collaboration combines biologic therapies with adult stem cell collection and cryopreservation services. Initial focus areas include physician education, training initiatives, and integrated service offerings for clinics, with Florida identified as a key market due to its supportive regulatory framework for stem cell applications.
  • IPG Medical CorporationcoreTechnology or IntegrationAcCELLerated Biologics serves as the exclusive US distributor of the Regenalase Laser System from IPG Medical Corporation. The Regenalase is a dual-delivery laser platform for musculoskeletal tissue treatment. The partnership was announced in August 2025, expanding AcCELLerated Biologics' device portfolio to include advanced laser therapy alongside its biologics offerings.
  • BroadlysupportingGTM or Marketing PartnerAcCELLerated Biologics partnered with Broadly to provide review growth solutions to physician clients. Broadly's platform automates patient follow-up for review collection, enabling practices to build online reviews and improve search engine rankings. The partnership integrates review management into AcCELLerated Biologics' broader marketing services offering.
  • EmCyte CorporationcoreTechnology or IntegrationAcCELLerated Biologics distributes EmCyte biologic processing systems including PurePRP, AbsolutePRP, and PureBMC product lines. These EmCyte systems are central to AcCELLerated Biologics' product portfolio, offering validated high platelet concentration performance. Independent testing by institutions including The Steadman Clinic validates EmCyte systems' superiority in platelet yields and cell concentration.
  • TendoNovacoreTechnology or IntegrationAcCELLerated Biologics distributes the TendoNova Ocelot Nano device, an FDA-cleared percutaneous tenotomy system. The Ocelot Nano uses a rapidly oscillating stainless-steel cutter for tendon debridement and fragmentation, with a dedicated port for targeted biologic delivery post-procedure. The device complements AcCELLerated Biologics' PRP and biologics portfolio.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Accellerated Biologics competitors and assessment

Company assessment

Direct peers

  • EmCyte Corporation: EmCyte is the manufacturer of PurePRP, AbsolutePRP, and PureBMC systems that AcCELLerated Biologics distributes, making it both supplier and closest functional peer in the PRP/biologics category.
  • Apex Biologix: Apex Biologix distributes PRP kits and provides regenerative medicine training to physicians, directly overlapping AcCELLerated Biologics' PRP distribution and RMTI-style education model.
  • Royal Biologics: Royal Biologics is a regenerative medicine distributor offering autologous biologics kits (PRP, BMAC) to orthopedic and pain physicians, directly competing in the same product categories.
  • Regenexx: Regenexx operates a network of regenerative medicine physician clinics using autologous biologics — a competing go-to-market model in orthobiologics that intersects with the same end-market of orthopedic and sports medicine physicians.
  • Isto Biologics: Isto Biologics develops and distributes autologous and allograft orthobiologics for spine, sports medicine, and orthopedic surgeons — directly comparable to AcCELLerated Biologics' biologics portfolio.

Broad incumbents

  • Bioventus: Bioventus is a publicly-traded orthobiologics company offering bone graft, PRP, and HA products that compete with AcCELLerated Biologics' portfolio in sports medicine and orthopedic channels.
  • Arthrex: Arthrex is a large orthopedic surgical device and biologics company with its own PRP/orthobiologics line, representing a well-capitalized incumbent in AcCELLerated Biologics' core orthopedic end market.
  • Terumo BCT: Terumo BCT manufactures cell processing and blood component separation systems, overlapping with AcCELLerated Biologics' PRP/BMC processing technology stack as a broader life-sciences incumbent.
  • Zimmer Biomet: Zimmer Biomet is a global orthopedic medtech leader with biologics offerings (PRP, bone graft substitutes), competing for the same hospital and ambulatory surgery center customers.
  • Stryker: Stryker is a diversified orthopedic and surgical device incumbent selling into the same physician and hospital channels targeted by AcCELLerated Biologics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Accellerated Biologics social profiles

Digital presence

Accellerated Biologics compliance and trust

Trust signal

Compliance2 records

Accellerated Biologics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Accellerated Biologics leadership team

Management profile

Number of profiles

Profiles8 records

Accellerated Biologics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Accellerated Biologics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Accellerated Biologics

What does Accellerated Biologics do?

Accellerated Biologics is a U.S. medical distribution company that supplies regenerative medicine biologics and medical devices to physicians and healthcare providers. The portfolio spans platelet-rich plasma (PRP) systems, bone marrow concentrate devices, adipose tissue processing kits, A2M/fibrinogen kits, photobiomodulation red light therapy devices, dual-delivery musculoskeletal laser systems, and a point-of-care platelet analyzer. The company also operates the Regenerative Medicine Training Institute (RMTI) for physician education and offers marketing services to medical practices.

Is Accellerated Biologics a public or private company?

Accellerated Biologics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Accellerated Biologics founded?

Accellerated Biologics was founded in 1999. It employs 11 to 50 people.

Where is Accellerated Biologics based?

Accellerated Biologics is headquartered in Tegueste, Spain, in the Europe region.

How does Accellerated Biologics make money?

Three revenue lines are on record. Biologics and Medical Device Product Sales are the primary driver. The others are education and Training Services and marketing Services for Physician Practices.

Who are Accellerated Biologics's main competitors?

Direct peers on record are EmCyte Corporation, Apex Biologix, Royal Biologics, Regenexx and Isto Biologics. Broad incumbents are Bioventus, Arthrex, Terumo BCT, Zimmer Biomet and Stryker.

Does Accellerated Biologics have an API?

No public API is recorded for Accellerated Biologics.

What industry is Accellerated Biologics in?

Accellerated Biologics's product category is Regenerative Medicine Medical Devices. Its primary akta.pro industry code is HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant), with a secondary code of CRAOAHAD, Specialty Pharmacy & Biologics Distribution. Its NAICS code is 423450 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals